|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 108.68 USD | -0.14% |
|
-0.20% | +2.64% |
| 09:40am | TD Cowen Adjusts Price Target on Merck to $120 From $100, Maintains Hold Rating | MT |
| 09:40am | Leerink Partners Adjusts Price Target on Merck to $124 From $114, Maintains Outperform Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 270B | |||||
| 930B | |||||
| 527B | |||||
| 379B | |||||
| 371B | |||||
| 289B |
Select your edition
All financial news and data tailored to specific country editions
